SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Matthew L. Maciejewski, Elizabeth A. Bayliss, Approaches to Comparative Effectiveness Research in Multimorbid Populations, Medical Care, 2014, 52, S23

    CrossRef

  2. 2
    Anirban Basu, Anupam B. Jena, Dana P. Goldman, Tomas J. Philipson, Robert Dubois, HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH, Health Economics, 2014, 23, 3
  3. 3
    Emily Edson-Heredia, Kimberly L Sterling, Carlos I Alatorre, Gebra Cuyun Carter, Rosirene Paczkowski, Victoria Zarotsky, Tomoko Maeda-Chubachi, Heterogeneity of Response to Biologic Treatment: Perspective for Psoriasis, Journal of Investigative Dermatology, 2014, 134, 1, 18

    CrossRef

  4. 4
    Levente Kriston, Ramona Meister, Incorporating uncertainty regarding applicability of evidence from meta-analyses into clinical decision making, Journal of Clinical Epidemiology, 2014, 67, 3, 325

    CrossRef

  5. 5
    Robert H. Dworkin, Michael P. McDermott, John T. Farrar, Alec B. O’Connor, Stephen Senn, Interpreting patient treatment response in analgesic clinical trials: Implications for genotyping, phenotyping, and personalized pain treatment, PAIN®, 2014, 155, 3, 457

    CrossRef

  6. 6
    Carlos O. Weiss, Ravi Varadhan, Milo A. Puhan, Andrew Vickers, Karen Bandeen-Roche, Cynthia M. Boyd, David M. Kent, Multimorbidity and Evidence Generation, Journal of General Internal Medicine, 2014, 29, 4, 653

    CrossRef

  7. 7
    J. van der Leeuw, P. M. Ridker, Y. van der Graaf, F. L. J. Visseren, Personalized cardiovascular disease prevention by applying individualized prediction of treatment effects, European Heart Journal, 2014, 35, 13, 837

    CrossRef

  8. 8
    D. Aronson, Subgroup analyses with special reference to the effect of antiplatelet agents in acute coronary syndromes, Thrombosis and Haemostasis, 2014, 112, 1, 16

    CrossRef

  9. 9
    David Xin Ding, The effect of experience, ownership and focus on productive efficiency: A longitudinal study of U.S. hospitals, Journal of Operations Management, 2014, 32, 1-2, 1

    CrossRef

  10. 10
    M.A. Espinoza, M.J. Sculpher, A. Manca, A. Basu, Encyclopedia of Health Economics, 2014,

    CrossRef

  11. 11
    Beth K. Potter, Pranesh Chakraborty, Jonathan B. Kronick, Kumanan Wilson, Doug Coyle, Annette Feigenbaum, Michael T. Geraghty, Maria D. Karaceper, Julian Little, Aizeddin Mhanni, John J. Mitchell, Komudi Siriwardena, Brenda J. Wilson, Ania Syrowatka, Achieving the “triple aim” for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework, Genetics in Medicine, 2013, 15, 6, 415

    CrossRef

  12. 12
    Kimberly E. Hoagwood, Don't Mourn: Organize. Reviving Mental Health Services Research for Healthcare Quality Improvement, Clinical Psychology: Science and Practice, 2013, 20, 1
  13. 13
    Autumn M. Gallegos, Michael Hoerger, Nancy L. Talbot, Jan A. Moynihan, Paul R. Duberstein, Emotional benefits of mindfulness-based stress reduction in older adults: the moderating roles of age and depressive symptom severity, Aging & Mental Health, 2013, 17, 7, 823

    CrossRef

  14. 14
    Martina Bientzle, Ulrike Cress, Joachim Kimmerle, How students deal with inconsistencies in health knowledge, Medical Education, 2013, 47, 7
  15. 15
    Donald E. Stull, Katherine Houghton, Identifying Differential Responders and Their Characteristics in Clinical Trials: Innovative Methods for Analyzing Longitudinal Data, Value in Health, 2013, 16, 1, 164

    CrossRef

  16. 16
    Paul Hodgkins, Ralf W Dittmann, Shaw Sorooshian, Tobias Banaschewski, Individual treatment response in attention-deficit/hyperactivity disorder: broadening perspectives and improving assessments, Expert Review of Neurotherapeutics, 2013, 13, 4, 425

    CrossRef

  17. 17
    Richard J. Willke, William Crown, Michael del Aguila, Mark J. Cziraky, Zeba M. Khan, Richard Migliori, Melding Regulatory, Pharmaceutical Industry, and U.S. Payer Perspectives on Improving Approaches to Heterogeneity of Treatment Effect in Research and Practice, Value in Health, 2013, 16, 6, S10

    CrossRef

  18. 18
    Brett Doble, Anthony Harris, David M Thomas, Stephen Fox, Paula Lorgelly, Multiomics medicine in oncology: assessing effectiveness, cost–effectiveness and future research priorities for the molecularly unique individual, Pharmacogenomics, 2013, 14, 12, 1405

    CrossRef

  19. 19
    Jiang Li, Jinhui Tian, Bin Ma, Kehu Yang, N-of-1 trials in China, Complementary Therapies in Medicine, 2013, 21, 3, 190

    CrossRef

  20. 20
    José A Sacristán, Patient-centered medicine and patient-oriented research: improving health outcomes for individual patients, BMC Medical Informatics and Decision Making, 2013, 13, 1, 6

    CrossRef

  21. 21
    Naihua Duan, Richard L. Kravitz, Christopher H. Schmid, Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research, Journal of Clinical Epidemiology, 2013, 66, 8, S21

    CrossRef

  22. 22
    Matthew L Maciejewski, Lesley H Curtis, Bryan Dowd, Study design elements for rigorous quasi-experimental comparative effectiveness research, Journal of Comparative Effectiveness Research, 2013, 2, 2, 159

    CrossRef

  23. 23
    Nirupama D Mitikiri, Emily S Reese, Arif Hussain, Eberechukwu Onukwugha, Daryl Pritchard, Robert Dubois, C Daniel Mullins, The emerging relevance of heterogeneity of treatment effect in clinical care: a study using stage IV prostate cancer as a model, Journal of Comparative Effectiveness Research, 2013, 2, 6, 605

    CrossRef

  24. 24
    Allan D. Sniderman, Kevin J. LaChapelle, Nikodem A. Rachon, Curt D. Furberg, The Necessity for Clinical Reasoning in the Era of Evidence-Based Medicine, Mayo Clinic Proceedings, 2013, 88, 10, 1108

    CrossRef

  25. You have free access to this content25
    Carlos O. Weiss, Jodi B. Segal, Ravi Varadhan, Assessing the applicability of trial evidence to a target sample in the presence of heterogeneity of treatment effect, Pharmacoepidemiology and Drug Safety, 2012, 21,
  26. 26
    Jennifer S. Lin, Evelyn P. Whitlock, Elizabeth Eckstrom, Rongwei Fu, Leslie A. Perdue, Tracy L. Beil, Rosanne M. Leipzig, Challenges in Synthesizing and Interpreting the Evidence from a Systematic Review of Multifactorial Interventions to Prevent Functional Decline in Older Adults, Journal of the American Geriatrics Society, 2012, 60, 11
  27. 27
    Gerald Gartlehner, Suzanne L. West, Alyssa J. Mansfield, Charles Poole, Elizabeth Tant, Linda J. Lux, Kathleen N. Lohr, CLINICAL HETEROGENEITY IN SYSTEMATIC REVIEWS AND HEALTH TECHNOLOGY ASSESSMENTS: SYNTHESIS OF GUIDANCE DOCUMENTS AND THE LITERATURE, International Journal of Technology Assessment in Health Care, 2012, 28, 01, 36

    CrossRef

  28. 28
    Kirsten Bell, Cochrane reviews and the behavioural turn in evidence-based medicine, Health Sociology Review, 2012, 21, 3, 313

    CrossRef

  29. 29
    Kirsten Bell, Cochrane reviews and the behavioural turn in evidence-based medicine, Health Sociology Review, 2012, 1205

    CrossRef

  30. 30
    Gebra Cuyún Carter, Ronald A Cantrell, Victoria Zarotsky, Virginia S Haynes, Glenn Phillips, Carlos I Alatorre, Iris Goetz, Rosirene Paczkowski, Lauren B Marangell, COMPREHENSIVE REVIEW OF FACTORS IMPLICATED IN THE HETEROGENEITY OF RESPONSE IN DEPRESSION, Depression and Anxiety, 2012, 29, 4
  31. 31
    William N. Evans, Craig Garthwaite, Estimating Heterogeneity in the Benefits of Medical Treatment Intensity, Review of Economics and Statistics, 2012, 94, 3, 635

    CrossRef

  32. 32
    Jose de Leon, Evidence-Based Medicine Versus Personalized Medicine, Journal of Clinical Psychopharmacology, 2012, 32, 2, 153

    CrossRef

  33. 33
    Richard J Willke, Zhiyuan Zheng, Prasun Subedi, Rikard Althin, C Daniel Mullins, From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer, BMC Medical Research Methodology, 2012, 12, 1, 185

    CrossRef

  34. 34
    Robert W Dubois, From Methods To Policy: A ‘one-size-fits-all’ policy ignores patient heterogeneity, Journal of Comparative Effectiveness Research, 2012, 1, 2, 119

    CrossRef

  35. 35
    Leonardo M. Fabbri, Cynthia Boyd, Piera Boschetto, Klaus F. Rabe, A. Sonia Buist, Barbara Yawn, Bruce Leff, David M. Kent, Holger J. Schünemann, How to Integrate Multiple Comorbidities in Guideline Development, Proceedings of the American Thoracic Society, 2012, 9, 5, 274

    CrossRef

  36. 36
    Sandra J. Tanenbaum, Improving the quality of medical care: the normativity of evidence-based performance standards, Theoretical Medicine and Bioethics, 2012, 33, 4, 263

    CrossRef

  37. 37
    Joshua J. Armstrong, Mu Zhu, John P. Hirdes, Paul Stolee, K-Means Cluster Analysis of Rehabilitation Service Users in the Home Health Care System of Ontario: Examining the Heterogeneity of a Complex Geriatric Population, Archives of Physical Medicine and Rehabilitation, 2012, 93, 12, 2198

    CrossRef

  38. 38
    Connie Chen, David Haddad, Joshua Selsky, Julia E Hoffman, Richard L Kravitz, Deborah E Estrin, Ida Sim, Making Sense of Mobile Health Data: An Open Architecture to Improve Individual- and Population-Level Health, Journal of Medical Internet Research, 2012, 14, 4, e112

    CrossRef

  39. 39
    Marc L. Berger, Nancy Dreyer, Fred Anderson, Adrian Towse, Art Sedrakyan, Sharon-Lise Normand, Prospective Observational Studies to Assess Comparative Effectiveness: The ISPOR Good Research Practices Task Force Report, Value in Health, 2012, 15, 2, 217

    CrossRef

  40. 40
    James E. Graham, Amol M. Karmarkar, Kenneth J. Ottenbacher, Small Sample Research Designs for Evidence-Based Rehabilitation: Issues and Methods, Archives of Physical Medicine and Rehabilitation, 2012, 93, 8, S111

    CrossRef

  41. 41
    Setareh A. Williams, Lizheng Shi, Susan K. Brenneman, Jonathan C. Johnson, Jessica C. Wegner, Vivian Fonseca, The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients, Journal of Diabetes and its Complications, 2012, 26, 5, 399

    CrossRef

  42. 42
    Klára Biró, Judit Zsuga, János Kormos, Róza Ádány, The effect of financing on the allocation and production efficiency of the Hungarian health care system — Placing primary care into focus, Society and Economy, 2012, 34, 3, 433

    CrossRef

  43. 43
    Harold C. Sox, Steven N. Goodman, The Methods of Comparative Effectiveness Research, Annual Review of Public Health, 2012, 33, 1, 425

    CrossRef

  44. 44
    Mark Helfand, Sean Tunis, Evelyn P. Whitlock, Stephen G. Pauker, Anirban Basu, Jon Chilingerian, Frank E. Harrell Jr., David O. Meltzer, Victor M. Montori, Donald S. Shepard, David M. Kent, A CTSA Agenda to Advance Methods for Comparative Effectiveness Research, Clinical and Translational Science, 2011, 4, 3
  45. 45
    David Atkins, Stephanie M. Chang, Gerald Gartlehner, David I. Buckley, Evelyn P. Whitlock, Elise Berliner, David Matchar, Assessing applicability when comparing medical interventions: AHRQ and the Effective Health Care Program, Journal of Clinical Epidemiology, 2011, 64, 11, 1198

    CrossRef

  46. 46
    Daryl R. Fourney, Gunnar Andersson, Paul M. Arnold, Joseph Dettori, Alex Cahana, Michael G. Fehlings, Dan Norvell, Dino Samartzis, Jens R. Chapman, Chronic Low Back Pain, Spine, 2011, 36, S1

    CrossRef

  47. 47
    Gunver Sophia Kienle, Hans-Ulrich Albonico, Lorenz Fischer, Martin Frei-Erb, Harald J. Hamre, Peter Heusser, Peter F. Matthiessen, Adrian Renfer, Helmut Kiene, Complementary Therapy Systems and Their Integrative Evaluation, EXPLORE: The Journal of Science and Healing, 2011, 7, 3, 175

    CrossRef

  48. 48
    Kirkham B. Wood, Peter Fritzell, Joseph R. Dettori, Robin Hashimoto, Teija Lund, Chris Shaffrey, Effectiveness of Spinal Fusion Versus Structured Rehabilitation in Chronic Low Back Pain Patients With and Without Isthmic Spondylolisthesis, Spine, 2011, 36, S110

    CrossRef

  49. You have free access to this content49
    R. Duggal, D. B. Menkes, Evidence-based medicine in practice, International Journal of Clinical Practice, 2011, 65, 6
  50. 50
    Michael D. Daubs, Daniel C. Norvell, Robert McGuire, Robert Molinari, Jeffrey T. Hermsmeyer, Daryl R. Fourney, J. P. Wolinsky, Darrel Brodke, Fusion Versus Nonoperative Care for Chronic Low Back Pain, Spine, 2011, 36, S96

    CrossRef

  51. 51
    Thomas E. Mroz, Daniel C. Norvell, Erika Ecker, Marcelo Gruenberg, Andrew Dailey, Darrel S. Brodke, Fusion Versus Nonoperative Management for Chronic Low Back Pain, Spine, 2011, 36, S75

    CrossRef

  52. 52
    Theodore J. Choma, James M. Schuster, Daniel C. Norvell, Joseph R. Dettori, Norman B. Chutkan, Fusion Versus Nonoperative Management for Chronic Low Back Pain, Spine, 2011, 36, S87

    CrossRef

  53. 53
    Kerianne H. Holman, Rodney A. Hayward, How to Make Market Competition Work in Healthcare, Medical Care, 2011, 49, 3, 240

    CrossRef

  54. 54
    Cynthia M. Boyd, Bruce Leff, Jennifer L. Wolff, Qilu Yu, Jing Zhou, Cynthia Rand, Carlos O. Weiss, Informing Clinical Practice Guideline Development and Implementation: Prevalence of Coexisting Conditions Among Adults with Coronary Heart Disease, Journal of the American Geriatrics Society, 2011, 59, 5
  55. 55
    Nicole B. Gabler, Naihua Duan, Sunita Vohra, Richard L. Kravitz, N-of-1 Trials in the Medical Literature, Medical Care, 2011, 49, 8, 761

    CrossRef

  56. 56
    Andrew P. White, Paul M. Arnold, Daniel C. Norvell, Erika Ecker, Michael G. Fehlings, Pharmacologic Management of Chronic Low Back Pain, Spine, 2011, 36, S131

    CrossRef

  57. 57
    Geetha A. Subramaniam, Diane Warden, Abu Minhajuddin, Marc J. Fishman, Maxine L. Stitzer, Bryon Adinoff, Madhukar Trivedi, Roger Weiss, Jennifer Potter, Sabrina A. Poole, George E. Woody, Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth, Journal of the American Academy of Child & Adolescent Psychiatry, 2011, 50, 11, 1120

    CrossRef

  58. 58
    Jamie O'Keeffe, John Willinsky, Lauren Maggio, Public Access and Use of Health Research: An Exploratory Study of the National Institutes of Health (NIH) Public Access Policy Using Interviews and Surveys of Health Personnel, Journal of Medical Internet Research, 2011, 13, 4, e97

    CrossRef

  59. 59
    Harry P. Selker, Robin Ruthazer, Norma Terrin, John L. Griffith, Thomas Concannon, David M. Kent, Random Treatment Assignment Using Mathematical Equipoise for Comparative Effectiveness Trials, Clinical and Translational Science, 2011, 4, 1
  60. 60
    Robert Froud, Sandra Eldridge, Francisco Kovacs, Alan Breen, Jenni Bolton, Kate Dunn, Julie Fritz, Anne Keller, Peter Kent, Henrik Hein Lauridsen, Raymond Ostelo, Tamar Pincus, Maurits Tulder, Steven Vogel, Martin Underwood, Reporting outcomes of back pain trials: A modified Delphi study, European Journal of Pain, 2011, 15, 10
  61. 61
    Iris Goetz, Gebra Cuyún Carter, Melanie Lucero, Victoria Zarotsky, Carlos I. Alatorre, Ronald A. Cantrell, Rosirene Paczkowski, Kimberly L. Sterling, Review of treatment response in rheumatoid arthritis: assessment of heterogeneity, Current Medical Research and Opinion, 2011, 27, 4, 697

    CrossRef

  62. 62
    R. Paul Thompson, Philosophy of Medicine, 2011,

    CrossRef

  63. 63
    R. A. Cantrell, C. I. Alatorre, E. J. Davis, V. Zarotsky, E. Le Nestour, G. Cuyún Carter, I. Goetz, R. Paczkowski, J. Sierra-Johnson, A review of treatment response in type 2 diabetes: assessing the role of patient heterogeneity, Diabetes, Obesity and Metabolism, 2010, 12, 10
  64. 64
    Erik Fernandez y Garcia, Hien Nguyen, Naihua Duan, Nicole B. Gabler, Richard L. Kravitz, Assessing Heterogeneity of Treatment Effects: Are Authors Misinterpreting Their Results?, Health Services Research, 2010, 45, 1
  65. 65
    R. Paul Thompson, Causality, mathematical models and statistical association: dismantling evidence-based medicine, Journal of Evaluation in Clinical Practice, 2010, 16, 2
  66. 66
    Paul R. Falzer, D. Melissa Garman, Contextual Decision Making and the Implementation of Clinical Guidelines: An Example From Mental Health, Academic Medicine, 2010, 85, 3, 548

    CrossRef

  67. 67
    Ian Shemilt, Miranda Mugford, Luke Vale, Kevin Marsh, Cam Donaldson, Michael Drummond, Evidence synthesis, economics and public policy, Research Synthesis Methods, 2010, 1, 2
  68. 68
    Razvigor Borislavov Darlenski, Neyko Valentinov Neykov, Vitan Dakov Vlahov, Nikolaï Konstantinov Tsankov, Evidence-based medicine: Facts and controversies, Clinics in Dermatology, 2010, 28, 5, 553

    CrossRef

  69. 69
    Sharon-Lise Normand, Danica Marinac-Dabic, Art Sedrakyan, Ronald Kaczmarek, Rethinking Analytical Strategies for Surveillance of Medical Devices, Medical Care, 2010, 48, S58

    CrossRef

  70. 70
    Rob Anderson, Systematic reviews of economic evaluations: utility or futility?, Health Economics, 2010, 19, 3
  71. 71
    Sherrie H. Kaplan, John Billimek, Dara H. Sorkin, Quyen Ngo-Metzger, Sheldon Greenfield, Who Can Respond to Treatment?, Medical Care, 2010, 48, S9

    CrossRef

  72. 72
    Paul R. Falzer, Melissa D. Garman, A conditional model of evidence-based decision making, Journal of Evaluation in Clinical Practice, 2009, 15, 6
  73. 73
    Anne E. Sales, Comorbidities, Frailty, and “Pay-off Time”, Medical Care, 2009, 47, 6, 607

    CrossRef

  74. 74
    John M. Brooks, Gang Fang, Interpreting treatment-effect estimates with heterogeneity and choice: Simulation model results, Clinical Therapeutics, 2009, 31, 4, 902

    CrossRef

  75. 75
    Kathryn Betts Adams, Holly C. Matto, Craig Winston LeCroy, LIMITATIONS OF EVIDENCE-BASED PRACTICE FOR SOCIAL WORK EDUCATION: UNPACKING THE COMPLEXITY, Journal of Social Work Education, 2009, 45, 2, 165

    CrossRef

  76. 76
    Karen L. Johnson, Tim Meyenburg, Physiological Rationale and Current Evidence for Therapeutic Positioning of Critically Ill Patients, AACN Advanced Critical Care, 2009, 20, 3, 228

    CrossRef

  77. 77
    M. Wagner, E. M. Balk, D. M. Kent, B. L. Kasiske, H. Ekberg, Subgroup Analyses in Randomized Controlled Trials: The Need for Risk Stratification in Kidney Transplantation, American Journal of Transplantation, 2009, 9, 10
  78. 78
    Donna H. Odierna, Lisa A. Bero, Systematic reviews reveal unrepresentative evidence for the development of drug formularies for poor and nonwhite populations, Journal of Clinical Epidemiology, 2009, 62, 12, 1268

    CrossRef

  79. 79
    Douglas F. Zatzick, Thomas Koepsell, Frederick P. Rivara, Using Target Population Specification, Effect Size, and Reach to Estimate and Compare the Population Impact of Two PTSD Preventive Interventions, Psychiatry: Interpersonal and Biological Processes, 2009, 72, 4, 346

    CrossRef

  80. 80
    T.-P. Van Staa, S. Rietbrock, E. Setakis, H. G. M. Leufkens, Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?, Journal of Internal Medicine, 2008, 264, 5
  81. 81
    David S. Salkever, Stephen Johnston, Mustafa C. Karakus, Nicholas S. Ialongo, Eric P. Slade, Elizabeth A. Stuart, Enhancing the Net Benefits of Disseminating Efficacious Prevention Programs: A Note on Target Efficiency with Illustrative Examples, Administration and Policy in Mental Health and Mental Health Services Research, 2008, 35, 4, 261

    CrossRef

  82. You have free access to this content82
    Andrew Miles, Michael Loughlin, Andreas Polychronis, Evidence-based healthcare, clinical knowledge and the rise of personalised medicine, Journal of Evaluation in Clinical Practice, 2008, 14, 5
  83. 83
    Cynthia M. Boyd, Christine S. Ritchie, Edmond F. Tipton, Stephanie A. Studenski, Darryl Wieland, From Bedside to Bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults, Aging Clinical and Experimental Research, 2008, 20, 3, 181

    CrossRef

  84. 84
    M. Cameron Hay, Thomas S. Weisner, Saskia Subramanian, Naihua Duan, Edmund J. Niedzinski, Richard L. Kravitz, Harnessing experience: exploring the gap between evidence-based medicine and clinical practice, Journal of Evaluation in Clinical Practice, 2008, 14, 5
  85. 85
    Stephen. Pilling, History, context, process, and rationale for the development of clinical guidelines, Psychology and Psychotherapy: Theory, Research and Practice, 2008, 81, 4
  86. 86
    Jennifer L. Baumbusch, Sheryl Reimer Kirkham, Koushambhi Basu Khan, Heather McDonald, Pat Semeniuk, Elsie Tan, Joan M. Anderson, Pursuing common agendas: A collaborative model for knowledge translation between research and practice in clinical settings, Research in Nursing & Health, 2008, 31, 2
  87. 87
    Lona Mody, Douglas K. Miller, Joanne M. McGloin, Marcie Freeman, Edward R. Marcantonio, Jay Magaziner, Stephanie Studenski, Recruitment and Retention of Older Adults in Aging Research, Journal of the American Geriatrics Society, 2008, 56, 12
  88. 88
    DONNA M. ZULMAN, SANDEEP VIJAN, GILBERT S. OMENN, RODNEY A. HAYWARD, The Relative Merits of Population-Based and Targeted Prevention Strategies, Milbank Quarterly, 2008, 86, 4
  89. 89
    RICHARD L. KRAVITZ, NAIHUA DUAN, EDMUND J. NIEDZINSKI, M. CAMERON HAY, SASKIA K. SUBRAMANIAN, THOMAS S. WEISNER, What Ever Happened to N-of-1 Trials? Insiders' Perspectives and a Look to the Future, Milbank Quarterly, 2008, 86, 4
  90. 90
    Daniel B. Carr, When Bad Evidence Happens to Good Treatments, Regional Anesthesia and Pain Medicine, 2008, 33, 3, 229

    CrossRef

  91. 91
    Grant T. Savage, Eric S. Williams, Patient Safety and Health Care Management, 2008,

    CrossRef

  92. 92
    Jonathan L Rees, Casting Light on Evidence, Journal of Investigative Dermatology, 2007, 127, 7, 1570

    CrossRef

  93. 93
    David Atkins, Creating and Synthesizing Evidence With Decision Makers in Mind, Medical Care, 2007, 45, Suppl 2, S16

    CrossRef

  94. 94
    Martin Fortin, Cynthia M. Boyd, Debate on DEBATE, American Heart Journal, 2007, 153, 5, e29

    CrossRef

  95. 95
    C. M. Boyd, C. O. Weiss, J. Halter, K. C. Han, W. B. Ershler, L. P. Fried, Framework for Evaluating Disease Severity Measures in Older Adults With Comorbidity, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2007, 62, 3, 286

    CrossRef

  96. 96
    Michael J. McLaughlin, Healthcare Policy Implications of Heterogeneity of Treatment Effects, The American Journal of Medicine, 2007, 120, 4, S32

    CrossRef

  97. 97
    John M. Brooks, Elizabeth A. Chrischilles, Heterogeneity and the Interpretation of Treatment Effect Estimates From Risk Adjustment and Instrumental Variable Methods, Medical Care, 2007, 45, Suppl 2, S123

    CrossRef

  98. 98
    Sheldon Greenfield, Richard Kravitz, Naihua Duan, Sherrie H. Kaplan, Heterogeneity of Treatment Effects: Implications for Guidelines, Payment, and Quality Assessment, The American Journal of Medicine, 2007, 120, 4, S3

    CrossRef

  99. 99
    Rachel M. Werner, Sheldon Greenfield, Constance Fung, Barbara J. Turner, Measuring Quality of Care in Patients With Multiple Clinical Conditions: Summary of a Conference Conducted by the Society of General Internal Medicine, Journal of General Internal Medicine, 2007, 22, 8, 1206

    CrossRef

  100. 100
    Samuel C Durso, Prioritizing care for older adults with multiple comorbidities: working in the ‘zone of complexity’, Aging Health, 2007, 3, 6, 715

    CrossRef

  101. 101
    Robert M. Kaplan, Michael Ong, Rationale and Public Health Implications of Changing CHD Risk Factor Definitions, Annual Review of Public Health, 2007, 28, 1, 321

    CrossRef

  102. 102
    Mark V. Johnston, Mark Sherer, John Whyte, Applying Evidence Standards to Rehabilitation Research, American Journal of Physical Medicine & Rehabilitation, 2006, 85, 4, 292

    CrossRef

  103. You have free access to this content103
    Erratum, Milbank Quarterly, 2006, 84, 4
  104. 104
    Margaret L. Schwarze, Maliha A. Sayla, G. Caleb Alexander, Exploring Patient Preferences for Infrainguinal Bypass Operation, Journal of the American College of Surgeons, 2006, 202, 3, 445

    CrossRef

  105. 105
    Bradford H. Gray, In This Issue, Milbank Quarterly, 2006, 84, 3
  106. 106
    Susan Griffin, Karl Claxton, Neil Hawkins, Mark Sculpher, Probabilistic Analysis and Computationally Expensive Models: Necessary and Required?, Value in Health, 2006, 9, 4
  107. 107
    Cynthia M. Boyd, Bruce Leff, QUALITY OF CARE FOR OLDER PATIENTS WITH DIABETES MELLITUS WITH COMORBIDITY, Journal of the American Geriatrics Society, 2006, 54, 3
  108. 108
    BARBARA STARFIELD, LEIYU SHI, JAMES MACINKO, Contribution of Primary Care to Health Systems and Health, Milbank Quarterly, 2005, 83, 3
  109. 109
    Bibliography,
  110. 110
    Richard P. DeShon, Inferential Meta-Themes in Organizational Science Research: Causal Inference, System Dynamics, and Computational Models, Handbook of Psychology, Second Edition,
  111. 111
    Rob Anderson, Ian Shemilt, The Role of Economic Perspectives and Evidence in Systematic Review,